Development of an assay to screen for inhibitors of tau phosphorylation by cdk5 |
| |
Authors: | Ahn Jae Suk Musacchio Andrea Mapelli Marina Ni Jake Scinto Leonard Stein Ross Kosik Kenneth S Yeh Li-An |
| |
Affiliation: | Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, USA. |
| |
Abstract: | A high-throughput assay for tau phosphorylation by cdk5/p25 is described. Full-length recombinant tau was used as a substrate in the presence of saturating adenosine triphosphate (ATP). Using PHF-1, an antibody directed specifically against 2 tau phosphorylation epitopes (serine 396 and serine 404), an enzyme-linked immunosorbent assay (ELISA)-based colorimetric assay was formatted in 384-well plates. The assay was validated by measuring kinetic parameters for cdk5/p25 catalysis and known inhibitors. Rate constants for the site-specific phosphorylations at the PHF-1 epitopes were determined and suggested preferential phosphorylation at these sites. The performance of this assay in a high-throughput format was demonstrated and used to identify inhibitors of tau phosphorylation at specific epitopes phosphorylated by cdk5/p25. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|